Beckman Coulter Apolipoprotein Correction Solution
Taiwan·Risk Class 2·BECKMAN COULTER INC.·Registered Mar 29, 2017 – Mar 29, 2027Active- Analysis ID
- f0a0e38d6ec975229bf2cefb3e4cbc8f
- Customs Code
- DHA05602952701
- Manufacturer
- BECKMAN COULTER INC.
- Manufacturer Country
- United States
- Authorized Representative
- BECKMAN COULTER TAIWAN INC., TAIWAN BRANCH (U.S.A.)
- Intended Use
- This product is paired with the UniCel DxC system with Beckman Coulter apolipoprotein A-l and B reagents as a correction for this reagent.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1150 Calibrated Products
- Import Information
- import
- Registration Date
- Mar 29, 2017
- Expiry Date
- Mar 29, 2027
Top companies providing products similar to "Beckman Coulter Apolipoprotein Correction Solution"
Recently registered similar products
Access comprehensive regulatory information for Beckman Coulter Apolipoprotein Correction Solution in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number f0a0e38d6ec975229bf2cefb3e4cbc8f and manufactured by BECKMAN COULTER INC.. The authorized representative in Taiwan is BECKMAN COULTER TAIWAN INC., TAIWAN BRANCH (U.S.A.).
This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including BECKMAN COULTER INC., and 1 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.